Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/19/2009CA2722968A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009CA2722738A1 Fermentation process
11/19/2009CA2722600A1 Anti-hepcidin antibodies and methods of use
11/18/2009EP2119780A1 Genetically recombinant antibody composition having enhanced effector activity
11/18/2009EP2119453A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia
11/18/2009EP2119452A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis
11/18/2009EP2119451A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
11/18/2009EP2119450A2 Induction of mucosal tolerance to antigens
11/18/2009EP2119447A1 Vaccine therapy for choroidal neovascularization
11/18/2009EP2119365A1 Fermentation process
11/18/2009EP2118323A2 Detection of influenza virus
11/18/2009EP2118318A2 Gnaq mutations in melanoma
11/18/2009EP2118300A2 Prevention and treatment of synucleinopathic and amyloidogenic disease
11/18/2009EP2118267A2 Novel methods for modulating inflammatory and/or immune responses
11/18/2009EP2118145A2 Modified saccharides
11/18/2009EP2118142A2 Humaneered anti-factor b antibody
11/18/2009EP2118140A2 Human cytomegalovirus neutralising antibodies and use thereof
11/18/2009EP2118139A1 Antibodies specific for varicella zoster virus
11/18/2009EP2118133A2 Amelioration of cellular stress response
11/18/2009EP2118128A2 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
11/18/2009EP2117594A2 Pharmaceutical composition containing antibodies directed against the herv-w envelope
11/18/2009EP2117593A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
11/18/2009EP2117592A1 Methods and compositions for depleting specific cell populations from blood tissues
11/18/2009EP2117591A1 Reducing tumor growth
11/18/2009EP2117590A1 Non-specific immunostimulating agents
11/18/2009EP2117587A2 Bacterial extract for digestive or urinary tract disorders and process for its preparation
11/18/2009EP2117586A1 Treatment or prophylaxis of asthma
11/18/2009EP2117585A1 Compositions comprising polysaccharide conjugates and their use as vaccines
11/18/2009EP2117575A2 Methods and compositions related to clot binding compounds
11/18/2009EP2117571A2 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
11/18/2009EP2117305A2 Modification of exosomal components for use as a vaccine
11/18/2009EP1711518B1 Chimpanzee adenovirus vaccine carriers
11/18/2009EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009EP1451552B1 Reagents and methods useful for detecting diseases of the breast
11/18/2009EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use
11/18/2009EP1079875B2 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons
11/18/2009EP0914422B1 Mammalian genes involved in viral infection
11/18/2009EP0904112B1 Composition comprising il-1ra as interleukin-1 inhibitor and hyaluronan as controlled release polymer
11/18/2009EP0758904B1 Methods and compositions for the treatment of glomerulonephritis
11/18/2009EP0662133B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
11/18/2009CN101583629A Modified saccharides
11/18/2009CN101583627A Methods for reducing phosphate absorption
11/18/2009CN101583625A Anti-CD16 binding molecules
11/18/2009CN101583376A Improved stably tethered structures of defined compositions with multiple functions or binding specificities
11/18/2009CN101583359A Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas
11/18/2009CN101583357A Composition of mTOR antagonist and angiogenesis inhibitor for treating cancer
11/18/2009CN101580849A Dna-transfection system for generation of infectious influenza virus
11/18/2009CN101580546A Human anti human interferon alpha antibody and application thereof
11/18/2009CN101580542A Application of mycobacterium tuberculosis adhesion HBHA in diagnosing and treating tuberculosis
11/18/2009CN101580540A Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof
11/18/2009CN101580538A WT1-origin HLA-DR-binding antigen peptide
11/18/2009CN101580537A Human cytomegalovirus UL 49 gene antigenic peptide, antibody thereof and use thereof
11/18/2009CN101579528A HIV composite multi-epitope DNA vaccine and application thereof
11/18/2009CN101579527A HLA Specific human cytomegalovirus Multi-epitope adenovirus DNA Vaccine of Chinese population
11/18/2009CN101579523A Egg yolk immunoglobulins oral and throat spraying agent and preparation method thereof
11/18/2009CN101579522A Novel peptide-based vaccine used for domestic animal and preparation method thereof
11/18/2009CN101579521A Abortus Chlamydia psittaci vaccine and preparation method thereof
11/18/2009CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof
11/18/2009CN100560719C MELAN-A peptide analogue-virus-like-particle conjugates
11/18/2009CN100560136C Ferrite/bacille calmette-guerin vaccine/temperature sensing gel integration material and preparation thereof
11/18/2009CN100560131C Antibody targeting compounds
11/18/2009CN100560130C Tumor antigen based on products of the tumor suppressor gent WT1
11/17/2009US7619070 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
11/17/2009US7619069 Antibodies to TGF-beta 1
11/17/2009US7619068 Antiovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo; detecting Ovr110 overexpression
11/17/2009US7619065 Cystine-knot fold protein
11/17/2009US7619064 Bacillus thuringiensis gene with coleopteran activity
11/17/2009US7619063 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
11/17/2009US7619061 Antigen constructs useful in the detection and differentiation of antibodies to HIV
11/17/2009US7619058 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
11/17/2009US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009US7618942 Controlling insects by contacting with insecticidal Bacillus thuringiensis hybrid protein comprising domains I and II of first native B. thuringiensis delta-endotoxin Cry1A protein, domain III of second native B. thuringiensis delta-endotoxin Cry1F protein, and protoxin segment of native delta endotoxin
11/17/2009US7618936 Administering to a cancer cell exhibiting reduced WIF-1 expression an effective amount of a polypeptide operably linked to a signal sequence or fused to a heterologous amino acid sequence, wherein said administering inhibits cancer cell proliferation
11/17/2009US7618802 Compositions of coronaviruses with a recombination-resistant genome
11/17/2009US7618794 Method for controlling environmental allergens
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
11/17/2009US7618783 Anthrax specific antibodies
11/17/2009US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009US7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
11/17/2009US7618641 Functionally reconstituted viral membranes containing adjuvant
11/17/2009US7618640 Method and composition for reducing E. coli disease and enhancing performance
11/17/2009US7618637 Therapeutic mixture comprising chaperone protein for use in treatment and prevention of autoimmune, infectious and allergic disorders
11/17/2009US7618636 Sequences from the bacterium Neisseria meningitidis.
11/17/2009US7618635 Super-antigen fusion proteins and the use thereof
11/17/2009US7618634 Neurotoxic oligomers
11/17/2009US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/17/2009US7618632 Expression vector comprising nucleotide sequences coding glucocorticoid-induced tumor necrosis factor receptor protein (GITR) for use in diagnosis, prevention and treatment of cancer, infection, autoimmune, inflammatory and/or transplant rejection
11/17/2009US7618631 Treating ErbB2-expressing cancer in a human by administering an antibody which binds ErbB2 and comprises variable light (VL) domain and variable heavy (VH) domain amino acid sequences and an antiestrogen; antitumor and antimetastasis agents; side effect reduction
11/17/2009US7618630 Administering to an individual a therapeutically effective amount of an antagonist of an interaction between an alpha 4 subunit-bearing integrin and a ligand for an alpha 4 subunit-bearing integrin
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009US7618628 CD16A binding proteins and use for the treatment of immune disorders
11/17/2009US7618627 Monitoring apoptosis in tumor cells by the co-administration of ionizing radiation and an anti-integrin antibody; reducing proliferation of tumor cells
11/17/2009US7618626 Combination treatment for non-hematologic malignancies
11/17/2009US7618625 Compositions comprising large and small binding fragments of antibodies against the same toxin
11/17/2009US7618624 Weight control using an anti-lipase antibody
11/17/2009US7618613 Method for radiolabeling antibodies with yttrium-90
11/17/2009US7618394 Needleless syringe using supersonic gas flow for particle delivery
11/17/2009CA2444551C Microprojection array immunization patch and method
11/17/2009CA2318536C Method of and compositions for immunization with the pseudomonas v antigen
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 1823